Answers are grounded in this paper and cite their sources.
Cabotegravir-based PrEP is a highly effective additional PrEP option that will expand HIV prevention options. For successful roll-out, strategies for streamlined and accessible delivery of cabotegravir in real-world settings will need to be developed.
No takes yet. Share an insight, caveat, or question.
Spinelli et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: